A Study on Rheumatoid Arthritis Patients Treated With Rituximab

Sponsor
Hoffmann-La Roche
Study ID
NCT02622503
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Rituximab — DRUG
    This is an observational study. Patients with rheumatoid arthritis and having received treatment previously will be assessed for the treatment responses.

Study Details

The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.

Key Dates

Start date
Apr 30, 2008
Status verified
Dec 2016
Primary completion
Aug 31, 2008
Completion
Aug 31, 2008

Study Design

Enrollment
81 participants (actual)

Arms

  • Arm: Patients with rheumatoid arthritis
    Patients with rheumatoid arthritis receiving rituximab will be observed for treatment responses.

Primary Outcome Measure

Information on previous RA treatments [ Time Frame: 3 months ]

Related Studies